Document is current
Any future updates will be listed below
-
Authors
Li, Haiwen https://orcid.org/0000-0003-4801-085X
Wang, Peipei https://orcid.org/0000-0003-1431-2139
Zhang, Chen
Zuo, Yuanbojiao
Zhou, Yuan https://orcid.org/0000-0002-9365-7460
Han, Renzhi https://orcid.org/0000-0002-8202-9186
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL116546)
- License Information
-
More Information
Article History
Received: 29 July 2022
Accepted: 20 March 2023
First Online: 30 March 2023
Competing interests
: The Ohio State University has filed a provisional patent application (application number: 63/421,383; inventors: R.H. and H.L.) based on the gene therapy work and Bortezomib treatment work reported in this paper. The remaining authors declare no competing interests.
